Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 30, 2011
Extended ICD/CRT-D program offers warranties up to 10 years
-
Nov 30, 2011
New family of cardiac devices offers excellent longevity and industry's longest warranty.
-
Nov 22, 2011
Approval marks transition to internally manufactured everolimus-eluting stent in the U.S.
-
Nov 18, 2011
Boston Scientific will participate in the healthcare conference on November 30, 2011. Learn how to watch the webcast or replay.
-
Nov 16, 2011
Innovative left atrial appendage closure device offers proven alternative to anticoagulant drugs for patients in atrial fibrillation at high risk for stroke.
-
Nov 15, 2011
Legislation seeks to improve the ability of companies like Boston Scientific to safely, efficiently and predictably bring new technologies to market.
-
Nov 11, 2011
Positive results from COBRA trial presented at TCT
-
Nov 11, 2011
EVOLVE trial evaluates fourth-generation everolimus-eluting coronary stent with ultra-thin abluminal bioabsorbable polymer.
-
Nov 8, 2011
Carotid WALLSTENT shown to be a safe alternative to carotid endarterectomy (CEA) in patients with carotid artery stenosis who are at increased risk for surgery.
-
Nov 8, 2011
PLATINUM Long Lesion clinical results presented at TCT show no cardiac death, heart attack or stent thrombosis at one year.